Nuri Gueven Selected Research

idebenone

1/2021	Novel Short-Chain Quinones to Treat Vision Loss in a Rat Model of Diabetic Retinopathy.
1/2021	Idebenone: When an antioxidant is not an antioxidant.
9/2020	Idebenone Protects against Spontaneous Chronic Murine Colitis by Alleviating Endoplasmic Reticulum Stress and Inflammatory Response.
1/2020	Idebenone Protects against Acute Murine Colitis via Antioxidant and Anti-Inflammatory Mechanisms.
1/2012	Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
3/2011	NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nuri Gueven Research Topics

Disease

10	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2015 - 08/2002
8	Neoplasms (Cancer) 10/2021 - 08/2002
8	Mitochondrial Diseases (Mitochondrial Disease) 03/2021 - 03/2011
6	Colitis 01/2021 - 01/2015
5	Body Weight (Weight, Body) 01/2021 - 01/2015
5	Inflammation (Inflammations) 01/2021 - 01/2015
5	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 01/2016
4	Genomic Instability 07/2008 - 08/2002
3	Ulcerative Colitis 01/2020 - 01/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2019 - 09/2006
3	Ataxia (Dyssynergia) 05/2013 - 06/2007
2	Medulloblastoma 05/2022 - 11/2020
2	Gliosis 01/2021 - 01/2012
2	Disease Progression 01/2021 - 01/2016
2	Hemorrhage 01/2015 - 01/2015
2	autosomal recessive 1 Spinocerebellar ataxia 05/2013 - 07/2006
2	Apraxias (Dyspraxia) 03/2010 - 06/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2006 - 08/2004
1	Angina Pectoris 05/2022
1	Hypertension (High Blood Pressure) 05/2022
1	Glioma (Gliomas) 05/2022
1	Chronic Pain 10/2021
1	Pain (Aches) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Herpes Zoster 01/2021
1	Dementia (Dementias) 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Relapsing-Remitting Multiple Sclerosis 10/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020
1	Wasting Syndrome (Wasting Disease) 01/2020
1	Necrosis 10/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Optic Nerve Diseases (Optic Neuropathy) 06/2016
1	Vision Disorders (Hemeralopia) 06/2016
1	Diarrhea 01/2015
1	Edema (Dropsy) 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2012
1	MELAS Syndrome (Syndrome, MELAS) 03/2011

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2002
8	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 08/2002
6	QuinonesIBA 03/2021 - 03/2011
6	idebenoneIBA 01/2021 - 03/2011
5	Pharmaceutical PreparationsIBA 01/2021 - 02/2020
3	quinone (benzoquinone)IBA 03/2021 - 02/2020
3	Retinaldehyde (Retinal)IBA 01/2021 - 01/2012
3	SodiumIBA 01/2021 - 01/2015
3	Dextrans (Dextran)FDA Link 01/2021 - 01/2015
3	Metformin (Glucophage)FDA LinkGeneric 10/2019 - 01/2016
3	AnticoagulantsIBA 01/2015 - 01/2015
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2015 - 01/2014
2	NaphthoquinonesIBA 01/2021 - 03/2019
2	AntioxidantsIBA 01/2020 - 09/2006
2	Arginine (L-Arginine)FDA Link 10/2019 - 01/2016
2	CitrullineIBA 10/2019 - 01/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2019 - 01/2016
2	fucoidanIBA 01/2019 - 01/2015
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015 - 01/2015
2	Complementary DNA (cDNA)IBA 05/2004 - 01/2004
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 05/2022
1	MibefradilIBA 05/2022
1	Opioid Analgesics (Opioids)IBA 10/2021
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 01/2021
1	CalciumIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	OccludinIBA 01/2021
1	AgarIBA 11/2020
1	Dimethyl FumarateIBA 10/2020
1	MucinsIBA 09/2020
1	Cell Surface ReceptorsIBA 02/2020
1	DystrophinIBA 01/2020
1	Mucin-2IBA 01/2020
1	ProteomeIBA 01/2020
1	adenylosuccinateIBA 01/2020
1	BiguanidesIBA 10/2019
1	Amino Acids FDA Link 10/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	AmidesIBA 03/2019
1	FucoseIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	VenomsIBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 09/2015
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2015
1	DisaccharidesIBA 01/2015
1	CytokinesIBA 01/2015
1	Dextran SulfateIBA 01/2015
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2015
1	PolyphenolsIBA 01/2015
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2011
1	Ubiquinone Q1IBA 03/2011

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2006
1	Drug Therapy (Chemotherapy) 01/2015